We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Improved HIV Genotypic Resistance Assay

By HospiMedica staff writers
Posted on 02 Jan 2001
An improved HIV genotypic resistance assay is designed to be a more sensitive assay at low viral load levels. More...
It will also aid both doctors and patients by shortening the turnaround time for results and providing a more user-friendly report.

The new assay, called HIV GenoSure, was developed by Laboratory Corp. of America (Burlington, NC, USA), using the company's database of over 40,000 genotypic and phenotypic specimens. The company created a mutational cluster analysis (MCA) software program to interpret genotypic results as either "sensitive,” "resistance possible,” or "resistant.” LabCorp also offers the HIV GenoSure Plus Assay, a genotyping test plus a predictive phenotype result using a correlation database.

"As one of the largest providers of HIV testing services in the United States, we are committed to advancing the state of the art in genotypic resistance testing,” said Myla P. Lai-Goldman, M.D., executive vice president and medical director at LabCorp.



Related Links:
LabCorp

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Glucose Meter
StatStrip®
New
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.